Skip to content
10-Q

Quarterly Report

BIOPLUS LIFE CORP

0001493152-21-000499

← back to feed
Filed
Jan 8, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 12, 2020 362.91M sh
Current Liabilities Q3 2020 · Sep 30, 2020 $872.8K
Current Liabilities Q3 2020 · Dec 31, 2019 $782.81K
Total Liabilities Q3 2020 · Sep 30, 2020 $1.55M
Total Liabilities Q3 2020 · Dec 31, 2019 $1.47M
Current Assets Q3 2020 · Sep 30, 2020 $1.37M
Current Assets Q3 2020 · Dec 31, 2019 $989.71K
Operating Income Q3 2020 · Sep 30, 2020 $119.73K
Operating Income Q3 2020 · Sep 30, 2020 $298.43K
Operating Income Q3 2020 · Sep 30, 2019 $40.25K
Operating Income restated Q3 2020 · Sep 30, 2019 $6.27K
Cash And Equivalents Q3 2020 · Dec 31, 2019 $210.74K
Total Assets Q3 2020 · Dec 31, 2019 $3.21M
Net Income Q3 2020 · Dec 31, 2019 −$93.19K
Net Income Q3 2020 · Sep 30, 2019 $40.25K
Net Income Q3 2020 · Sep 30, 2019 $7.37K
Capex Q3 2020 · Sep 30, 2019 $33.69K
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$56.06K
Sga Expense Q3 2020 · Sep 30, 2019 $188.02K
Sga Expense Q3 2020 · Sep 30, 2019 $559.25K
Gross Profit Q3 2020 · Sep 30, 2019 $236.12K
Gross Profit Q3 2020 · Sep 30, 2019 $587.03K
Cost Of Revenue Q3 2020 · Sep 30, 2019 $210.31K
Cost Of Revenue Q3 2020 · Sep 30, 2019 $614.3K
Revenue Q3 2020 · Sep 30, 2019 $446.44K
Revenue Q3 2020 · Sep 30, 2019 $1.2M
Stockholders Equity Q3 2020 · Dec 31, 2018 $1.8M